Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Proceedings of the Royal Society of Medicine
|
January 1, 1977
Three large-scale clinical trials of aspirin in the USA
W F Krol
Controlled Clinical Trials
|
December 1, 1983
The Coronary Drug Project. Closing down the study
W F Krol
JAMA
|
February 13, 1981
Aspirin and recurrent myocardial infarction
W F Krol
Psychosomatic Medicine
|
September 1, 1973
Letter: Reliability study of the Holmes and Rahe Schedule of Recent Experiences
W F Krol, J Schonfield
Controlled Clinical Trials
|
October 1, 1994
Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD)
W O Williford, W F Krol, S J Spechler
Journal of Clinical Epidemiology
|
September 1, 1993
Comparison of eligible randomized patients with two groups of ineligible patients: can the results of the VA Total Parenteral Nutrition clinical trial be generalized?
W O Williford, W F Krol, G P Buzby
Controlled Clinical Trials
|
December 1, 1983
The Coronary Drug Project. External quality control programs
P L Canner, W F Krol, S A Forman
Thrombosis and Haemostasis
|
April 25, 1989
Significance: clinical or statistical?
S F Bingham, J F Collins, D G Weiss, et al.
Thrombosis and Haemostasis
|
October 30, 1985
White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction
G D Lowe, S G Machado, W F Krol, et al.
The New England Journal of Medicine
|
December 14, 2001
Naltrexone in the treatment of alcohol dependence
J H Krystal, J A Cramer, W F Krol, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Proceedings of the Royal Society of Medicine
|
January 1, 1977
Three large-scale clinical trials of aspirin in the USA
W F Krol
Controlled Clinical Trials
|
December 1, 1983
The Coronary Drug Project. Closing down the study
W F Krol
JAMA
|
February 13, 1981
Aspirin and recurrent myocardial infarction
W F Krol
Psychosomatic Medicine
|
September 1, 1973
Letter: Reliability study of the Holmes and Rahe Schedule of Recent Experiences
W F Krol, J Schonfield
Controlled Clinical Trials
|
October 1, 1994
Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD)
W O Williford, W F Krol, S J Spechler
Journal of Clinical Epidemiology
|
September 1, 1993
Comparison of eligible randomized patients with two groups of ineligible patients: can the results of the VA Total Parenteral Nutrition clinical trial be generalized?
W O Williford, W F Krol, G P Buzby
Controlled Clinical Trials
|
December 1, 1983
The Coronary Drug Project. External quality control programs
P L Canner, W F Krol, S A Forman
Thrombosis and Haemostasis
|
April 25, 1989
Significance: clinical or statistical?
S F Bingham, J F Collins, D G Weiss, et al.
Thrombosis and Haemostasis
|
October 30, 1985
White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction
G D Lowe, S G Machado, W F Krol, et al.
The New England Journal of Medicine
|
December 14, 2001
Naltrexone in the treatment of alcohol dependence
J H Krystal, J A Cramer, W F Krol, et al.
Page
of 2